The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model

INTRODUCTION: Management of phenylketonuria (PKU) is mainly achieved through dietary control with limited intake of phenylalanine (Phe) from food, supplemented with low protein (LP) food and a mixture of free synthetic (FS) amino acids (AA) (FSAA). Casein glycomacropeptide (CGMP) is a natural peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahring, Kirsten K., Dagnæs-Hansen, Frederik, Brüel, Annemarie, Christensen, Mette, Jensen, Erik, Jensen, Thomas G., Johannsen, Mogens, Johansen, Karen S., Lund, Allan M., Madsen, Jesper G., Brøndum-Nielsen, Karen, Pedersen, Michael, Sørensen, Lambert K., Kjolby, Mads, Møller, Lisbeth B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751992/
https://www.ncbi.nlm.nih.gov/pubmed/35015767
http://dx.doi.org/10.1371/journal.pone.0261150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751992/
https://www.ncbi.nlm.nih.gov/pubmed/35015767
http://dx.doi.org/10.1371/journal.pone.0261150

Ejemplares similares